Primary Job Title Founder, Chief Executive Officer, Board Member & President Primary Organization Collaborative Drug Discovery
Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn X (Twitter) View on X
Barry A. Bunin, Ph.D. is the CEO of Collaborative Drug Discovery. Barry Bunin has overseen over $18 million in business transactions. Prior to CDD, Barry Bunin was an Entrepreneur in Residence with Eli Lilly & Co. Before that he was the founding CEO, President, & CSO of Libraria (now Eidogen-Sertanty). At Libraria, Barry Bunin led a team
that integrated exhaustive reaction capture (synthetic chemistry) with gene-family wide SAR capture (medicinal chemistry). On the scientific side, he co-authored “Chemoinformatics: Theory, Practice, and Products†(Springer-Verlag), a text that overviews modern chemoinformatics technologies, and “The Combinatorial Index†(Academic Press), a widely used text on high-throughput chemical synthesis. In the lab, Barry Bunin did medicinal synthetic chemistry developing patented new chemotypes for protease inhibition at Axys Pharmaceuticals (now Celera) and RGD mimics to inhibit GP-IIbIIIa at Genentech.
Barry Bunin received his B.A. from Columbia University and his Ph.D. from UC Berkeley, where he synthesized and tested the initial 1,4-benzodiazepine libraries with Professor Jonathan Ellman.
